Cargando…
Japanese Clinical Practice Guideline for Diabetes 2019
Autores principales: | Araki, Eiichi, Goto, Atsushi, Kondo, Tatsuya, Noda, Mitsuhiko, Noto, Hiroshi, Origasa, Hideki, Osawa, Haruhiko, Taguchi, Akihiko, Tanizawa, Yukio, Tobe, Kazuyuki, Yoshioka, Narihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378414/ https://www.ncbi.nlm.nih.gov/pubmed/33021749 http://dx.doi.org/10.1111/jdi.13306 |
Ejemplares similares
-
Japanese Clinical Practice Guideline for Diabetes 2016
por: Haneda, Masakazu, et al.
Publicado: (2018) -
Cluster‐randomized trial to improve the quality of diabetes management: The study for the efficacy assessment of the standard diabetes manual (SEAS‐DM)
por: Noto, Hiroshi, et al.
Publicado: (2016) -
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
por: Kaku, Kohei, et al.
Publicado: (2014) -
The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016) -
Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study
por: Araki, Eiichi, et al.
Publicado: (2019)